Want to be part of history? Want to contribute to future progress in understanding, diagnosing, and treating Duchenne?
Join us for PPMD’s 2022 Advocacy Conference. Over the last 21 years, Duchenne Advocacy has resulted in…
- Over $600 million in funding for Duchenne related programs at the National Institutes of Health, Center for Disease Control, and Department of Defense.
- A standard of care established and recently updated for all those diagnosed with Duchenne, which has markedly improved the quality of life and extended lifespan.
- An ever growing Duchenne drug development pipeline with over 40 companies developing drugs for Duchenne.
There is no registration fee associated with this event. Only your time and energy are needed to join a movement and help keep Duchenne as a priority in our legislative environment.